Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen binding refers to the interaction between collagen molecules and various proteins, receptors, or cells that recognize and attach to collagen. Collagen is the primary structural protein in connective tissues such as bone, tendon, skin, cartilage, ligaments, and blood vessels. Its unique triple-helix structure provides tensile strength and resilience to tissues. Collagen binding is essential for maintaining tissue integrity by holding connective tissues together. It organizes cells into tissues, regulating cell growth and morphology. These interactions are crucial for processes like wound healing, hemostasis, angiogenesis, biomineralization, tissue remodeling, and cell adhesion. Disruption or abnormality in collagen binding can lead to diseases such as fibrosis, atherosclerosis, cancer metastasis and brittle bone disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen Binding.